CAI fund manager activity
Caris Life Sciences, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q2 2025 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Philippe Laffont - Coatue Management | Trimmed | 9,819,992 | $264,943,384 | 0.66% | May 15, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 67,186 | $1,812,678 | 0.01% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Philippe Laffont - Coatue Management | No change | 10,142,198 | $306,801,490 | 0.75% | Nov 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | New | 33,203 | $1,004,391 | 0.00% | Nov 14, 2025 |